MARKET

TTOO

TTOO

T2 Biosystems
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9781
-0.0319
-3.16%
After Hours: 0.9800 +0.0019 +0.19% 19:59 09/24 EDT
OPEN
1.000
PREV CLOSE
1.010
HIGH
1.010
LOW
0.9701
VOLUME
1.41M
TURNOVER
--
52 WEEK HIGH
3.790
52 WEEK LOW
0.8536
MARKET CAP
162.21M
P/E (TTM)
-3.3100
1D
5D
1M
3M
1Y
5Y
T2 Biosystems to Unveil New Data at September Conferences
Leading rapid diagnostics company to share new research at industry conferences throughout Sepsis Awareness MonthLEXINGTON, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing patho...
GlobeNewswire · 09/14 14:05
Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
Zacks · 09/13 12:14
41 Stocks Moving In Friday's Mid-Day Session
Gainers
Benzinga · 09/10 16:23
Sector Update: Health Care Stocks Ail During Friday Trading
MT Newswires · 09/10 16:11
Sector Update: Health Care Stocks Ailing Friday
MT Newswires · 09/10 13:45
20 Stocks Moving in Friday's Pre-Market Session
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
Benzinga · 09/10 11:02
T2 Biosystems' Stock Jumps As Its COVID-19 Molecular Test Can Detect Mu, Iota Variants
Benzinga · 09/10 10:47
T2 Biosystems Says Molecular Diagnostic Test Able to Detect Mu, Iota Variants of SARS-CoV-2 Virus - Shares Climb Pre-Bell
MT Newswires · 09/10 06:41
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TTOO. Analyze the recent business situations of T2 Biosystems through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TTOO stock price target is 2.200 with a high estimate of 3.000 and a low estimate of 1.250.
EPS
Institutional Holdings
Institutions: 128
Institutional Holdings: 34.43M
% Owned: 20.76%
Shares Outstanding: 165.85M
TypeInstitutionsShares
Increased
21
3.76M
New
13
359.15K
Decreased
19
1.95M
Sold Out
13
757.54K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.19%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Chairman/President/Chief Executive Officer/Director
John Sperzel
Chief Financial Officer
John Sprague
Chief Operating Officer
Alec Barclay
Vice President/General Counsel
Michael Gibbs
Other
Aparna Ahuja
Other
Anthony Pare
Lead Director/Independent Director
John Cumming
Director
Seymour Liebman
Independent Director
Thierry Bernard
Independent Director
David Elsbree
Independent Director
Ninfa Saunders
Independent Director
Robin Toft
No Data
About TTOO
T2 Biosystems, Inc. is an in-vitro diagnostics company. The Company is using its T2MR technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its products include the T2Dx Instrument, T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel that are all powered by the T2MR technology. Its development efforts target sepsis. Utilizing T2MR, the Company has developed and received the United States Federal Drug Administration marketing clearance for the T2Dx Instrument, an instrument for detecting pathogens associated with sepsis and Lyme disease, as well as other applications. Its T2SARS-CoV-2 Panel is designed to detect SARS-CoV-2, the virus that is responsible for COVID-19 infections.

Webull offers kinds of T2 Biosystems Inc stock information, including NASDAQ:TTOO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTOO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TTOO stock methods without spending real money on the virtual paper trading platform.